High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: a review of the literature

Nutrition Research

Volumn 29, Issue 4, 2009, Pages 221-228

  Iwamoto, Jun ^a   Sato, Yoshihiro ^b   Takeda, Tsuyoshi ^a   Matsumoto, Hideo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Mitate Hospital   (Japan)

Author keywords

Fracture; Geometry; Postmenopausal women; ucOC; Vitamin K

Indexed keywords

FARNOQUINONE; MENADIONE; MENAQUINONE; MENAQUINONE 7; MENATETRENONE; OSTEOCALCIN; PHYTOMENADIONE; PLACEBO; UNCLASSIFIED DRUG; VITAMIN K GROUP;

BONE DENSITY; BONE STRENGTH; BONE TURNOVER; CARBOXYLATION; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FEMUR NECK; FRACTURE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL SYMPTOM; HUMAN; INCIDENCE; MEDLINE; META ANALYSIS; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SIDE EFFECT; SKELETON; SYSTEMATIC REVIEW; VITAMIN INTAKE; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMUR NECK; FRACTURES, BONE; HUMANS; OSTEOCALCIN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN K;

EID: 65449164234     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2009.03.012     Document Type: Review

References (46)

1. Berkner K.L. Vitamin K-dependent carboxylation. Vitam Horm 78 (2008) 131-156
2. Berkner K.L. The vitamin K-dependent carboxylase. Annu Rev Nutr 25 (2005) 127-149
3. Berkner K.L., and Runge K.W. The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J Thromb Haemost 2 (2004) 2118-2132
4. Cranenburg E.C., Vermeer C., Koos R., Boumans M.L., Hackeng T.M., Bouwman F.G., et al. The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 45 (2008) 427-436
5. Schurgers L.J., Spronk H.M., Skepper J.N., Hackeng T.M., Shanahan C.M., Vermeer C., et al. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 5 (2007) 2503-2511
6. Wallin R., Schurgers L., and Wajih N. Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. Thromb Res 122 (2008) 411-417
7. Hauschka P.V., Lian J.B., Cole D.E.C., and Gundberg C.M. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69 (1989) 990-1047
8. Koshihara Y., and Hoshi K. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 12 (1997) 431-438
9. Shearer M.J. Vitamin K. Lancet 345 (1995) 229-234
10. Vermeer C., Jie K.S.G., and Knapen M.H.J. Role of vitamin K in bone metabolism. Annu Rev Nutr 15 (1995) 1-22
11. Tabb M.M., Sun A., Zhou C., Grün F., Errandi J., Romero K., et al. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 278 (2003) 43919-43927
12. The WHO Scientific Group. Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 921 (2003) 86-109
13. Cockayne S., Adamson J., Lanham-New S., Shearer M.J., Gilbody S., and Torgerson D.J. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166 (2006) 1256-1261
14. Okano T., Shimomura Y., Yamane M., Suhara Y., Kamao M., Sugiura M., et al. Conversion of phylloquinone (Vitamin K1) into menaquinone-4 (Vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem 283 (2008) 11270-11279
15. Schurgers L.J., Teunissen K.J., Hamulyák K., Knapen M.H., Vik H., and Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 109 (2007) 3279-3283
16. Bolton-Smith C., McMurdo M.E., Paterson C.R., Mole P.A., Harvey J.M., Fenton S.T., et al. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J Bone Miner Res 22 (2007) 509-519
17. Cheung A.M., Tile L., Lee Y., Tomlinson G., Hawker G., Scher J., et al. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLos Med 5 (2008) e196
18. Knapen M.H., Schurgers L.J., and Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 18 (2007) 963-972
19. Booth S.L., Dallal G., Shea M.K., Gundberg C., Peterson J.W., and Dawson-Hughes B. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 93 (2008) 1217-1223
20. Braam L.A., Knapen M.H., Geusens P., Brouns F., Hamulyák K., Gerichhausen M.J., et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 73 (2003) 21-26
21. Shiraki M., Shiraki Y., Aoki C., and Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15 (2000) 515-521
22. Inoue T., Fujita T., Kishimoto H., Makino T., Nakamura T., Nakamura T., et al. Randomized controlled study on the prevention of osteoporotic fractures (OF Study): a phase IV clinical study of 15-mg menatetrenone capsules. J Bone Miner Metab 27 (2009) 66-75
23. Orimo H., Fujita T., Onomura T., Inoue T., Kushida K., and Shiraki M. Clinical evaluation of soft capsule menatetrenone (Ea-0167) in the treatment of osteoporosis. Late Phase II Dose Study. J New Remedies Clinics 41 (1992) 1249-1279 [in Japanese]
24. Centre for Evidence-Based Medicene. Oxford-centre evidence based medicine. Levels of evidence and grades of recommendation. http://www.cebm.net/levels_of_evidence.asp
25. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., et al. Increased bone formation in osteocalcin-deficient mice. Nature 382 (1996) 448-452
26. Chattopadhyay N., and Brown E.M. Cellular "sensing" of extracellular calcium (Ca(2+)(0)): emerging roles in regulating diverse physiological functions. Cell Signal 12 (2000) 361-366
27. Pi M., Faber P., Ekema G., Jackson P.D., Ting A., Wang N., et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem 280 (2005) 40201-40209
28. Booth S.L., Tucker K.L., Chen H., Hannan M.T., Gagnon D.R., Cupples L.A., et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 71 (2000) 1201-1208
29. Kaneki M., Hodges S.J., Hosoi T., Fujiwara S., Lyons A., Crean S.J., et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition 17 (2001) 315-321
30. Szulc P., Chapuy M.C., Meunier P.J., and Delmas P.D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91 (1993) 1769-1774
31. Szulc P., Chapuy M.C., Meunier P.J., and Delmas P.D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 18 (1996) 487-488
32. Vergnaud P., Garnero P., Meunier P.J., Breart G., Kamihagi K., and Delmas P.D. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 82 (1997) 719-724
33. Luukinen H., Käkönen S.M., Pettersson K., Koski K., Laippala P., Lövgren T., et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15 (2000) 2473-2478
34. Feskanich D., Weber P., Willett W.C., Rockett H., Booth S.L., and Colditz G.A. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 69 (1999) 74-79
35. Tsugawa N., Shiraki M., Suhara Y., Kamao M., Ozaki R., Tanaka K., et al. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab 26 (2008) 79-85
36. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 285 (2001) 785-795
37. Kanis J.A., Johnell O., Oden A., Jonsson B., Dawsopn A., and Dere W. Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int 11 (2000) 120-127
38. Kinoshita H., Nakagawa K., Narusawa K., Goseki-Sone M., Fukushi-Irie M., Mizoi L., et al. A functional single nucleotide polymorphism in the vitamin-K-dependent gamma-glutamyl carboxylase gene (Arg325Gln) is associated with bone mineral density in elderly Japanese women. Bone 40 (2007) 451-456
39. Hara K., Akiyama Y., Nakamura T., Murota S., and Morita I. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain. Bone 16 (1995) 179-184
40. Hara K., Akiyama Y., Tajima T., and Shiraki M. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro. J Bone Miner Res 8 (1993) 535-542
41. Binkley N., Harke J., Krueger D., Engelke J., Vallarta-Ast N., Gemar D., et al. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density or geometry in healthy postmenopausal North American women. J Bone Miner Res (2008) [Online publication]
42. Sato Y., Inose M., Higuchi I., Higuchi F., and Kondo I. Changes in the supporting muscles of the fractured hip in elderly women. Bone 30 (2002) 325-330
43. Bischoff-Ferrari H.A., Dawson-Hughes B., Willett W.C., Staehelin H.B., Bazemore M.G., Zee R.Y., et al. Effect of vitamin D on falls: a meta-analysis. JAMA 291 (2004) 1999-2006
44. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., and Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293 (2005) 2257-2264
45. Nakamura K. Vitamin D insufficiency in Japanese populations: from the viewpoint of the prevention of osteoporosis. J Bone Miner Metab 24 (2006) 1-6
46. Jesudason D., Need A.G., Horowitz M., O'Loughlin P.D., Morris H.A., and Nordin B.E. Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone 31 (2002) 626-630